CRISPR Therapeutics AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRSP research report →
About the company
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's genetic code. Its extensive pipeline includes therapeutic candidates spanning multiple medical areas, such as blood disorders (hemoglobinopathies), various cancers (oncology), regenerative medicine, and rare conditions.
- CEO
- Samarth Kulkarni
- IPO
- 2016
- Employees
- 393
- HQ
- Zug, CH
Price Chart
- Market Cap
- $4.80B
- P/E
- -8.41
- P/S
- 1170.64
- P/B
- 2.64
- EV/EBITDA
- -9.46
- Div Yield
- 0.00%
- Gross Margin
- -5360.86%
- Op Margin
- -13408.29%
- Net Margin
- -13856.54%
- ROE
- -30.88%
- ROIC
- -21.09%
- Revenue
- $3.51M · -89.97%
- Net Income
- $-581,599,000 · -58.80%
- EPS
- $-6.47 · -49.08%
- Op Income
- $-568,318,000
- FCF YoY
- -139.11%
- 52W High
- $78.48
- 52W Low
- $40.76
- 50D MA
- $52.51
- 200D MA
- $55.53
- Beta
- 1.70
- Avg Volume
- 1.71M
Get TickerSpark's AI analysis on CRSP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | George Simeon | other | 13,000 |
| Jun 5, 26 | Behbahani Ali | other | 13,000 |
| Jun 5, 26 | Fardis Maria | other | 13,000 |
| Jun 5, 26 | Fleming Harold Edward | other | 13,000 |
| Jun 5, 26 | Greene John | other | 13,000 |
| Jun 5, 26 | High Katherine A | other | 13,000 |
| Jun 5, 26 | Mahatme Sandesh | other | 13,000 |
| Jun 5, 26 | Morrison Briggs | other | 13,000 |
| Jun 5, 26 | Rommel Christian | other | 13,000 |
| Jun 5, 26 | Treco Douglas A | other | 13,000 |
Our CRSP coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CRSP?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.